CymitQuimica logo

CAS 113665-84-2

:

Clopidogrel

Description:
Clopidogrel is an antiplatelet medication primarily used to prevent blood clots in patients with cardiovascular diseases, such as those who have experienced a heart attack or stroke. It functions as a prodrug, meaning it requires metabolic activation to exert its therapeutic effects. Clopidogrel selectively inhibits the P2Y12 adenosine diphosphate (ADP) receptor on platelets, thereby preventing platelet aggregation. The substance is typically administered orally and is well-absorbed in the gastrointestinal tract, although its bioavailability is affected by first-pass metabolism. Clopidogrel is characterized by its relatively low solubility in water and is often formulated as a bisulfate salt to enhance its stability and absorption. The drug has a half-life of approximately 8 hours, but its antiplatelet effects can last for several days due to irreversible binding to the P2Y12 receptor. Common side effects may include bleeding complications, gastrointestinal disturbances, and, in rare cases, hypersensitivity reactions. Overall, Clopidogrel plays a crucial role in the management of thrombotic disorders.
Formula:C16H16ClNO2S
InChI:InChI=1S/C16H16ClNO2S/c1-20-16(19)15(12-4-2-3-5-13(12)17)18-8-6-14-11(10-18)7-9-21-14/h2-5,7,9,15H,6,8,10H2,1H3/t15-/m0/s1
InChI key:InChIKey=GKTWGGQPFAXNFI-HNNXBMFYSA-N
SMILES:[C@H](C(OC)=O)(N1CC2=C(CC1)SC=C2)C3=C(Cl)C=CC=C3
Synonyms:
  • Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (S)-
  • Clopidogrel
  • Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)-
  • (S)-Methyl α-(4,5,6,7-tetrahydrothieno[3,2-c]pyridin-5-yl)-α-(o-chlorophenyl)acetate
  • (S)-(+)-Methyl (2-chlorophenyl)(6,7-dihydro-4H-thieno[3,2-c]pyrid-5-yl)acetate
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 9 products.
  • (S)-(+)-Clopidogrel Sulfate

    CAS:
    Formula:C16H16ClNO2S·H2SO4
    Purity:>98.0%(HPLC)(N)
    Color and Shape:White to Almost white powder to crystal
    Molecular weight:419.89

    Ref: 3B-C2556

    1g
    84.00€
    5g
    264.00€
  • Clopidogrel

    CAS:
    Clopidogrel (SR-25990C), a P2Y12 receptor antagonist, decreases platelet aggregation.
    Formula:C16H16ClNO2S
    Purity:98.23% - 98.83%
    Color and Shape:White Powder
    Molecular weight:321.82
  • Thieno[3,2-c]pyridine-5(4H)-acetic acid, α-(2-chlorophenyl)-6,7-dihydro-, methyl ester, (αS)-

    CAS:
    Formula:C16H16ClNO2S
    Purity:98%
    Color and Shape:Solid
    Molecular weight:321.8217

    Ref: IN-DA00099Q

    1g
    118.00€
    5g
    311.00€
    100mg
    65.00€
    250mg
    84.00€
  • Clopidogrel

    CAS:
    Clopidogrel
    Purity:≥98%
    Molecular weight:321.82g/mol

    Ref: 54-BUP17398

    100mg
    66.00€
    200mg
    93.00€
  • (S)-Methyl 2-(2-Chlorophenyl)-2-(6,7-Dihydrothieno[3,2-C]Pyridin-5(4H)-Yl)Acetate

    CAS:
    (S)-Methyl 2-(2-Chlorophenyl)-2-(6,7-Dihydrothieno[3,2-C]Pyridin-5(4H)-Yl)Acetate
    Purity:98%
    Molecular weight:321.82g/mol

    Ref: 54-OR1027848

    1g
    106.00€
    5g
    310.00€
    25g
    1,243.00€
    100mg
    36.00€
    250mg
    51.00€
  • Clopidogrel

    CAS:
    Formula:C16H16ClNO2S
    Purity:≥ 90.0%
    Color and Shape:Light yellow viscous liquid
    Molecular weight:321.82

    Ref: 7W-GP2599

    ne
    To inquire
  • (S)-Clopidogrel

    CAS:
    Color and Shape:Neat

    Ref: 04-C11686930

    25mg
    149.00€
  • Clopidogrel

    CAS:
    Formula:C16H16ClNO2S
    Purity:>98.0%(HPLC)(qNMR)
    Color and Shape:White or Colorless to Light yellow to Light orange powder to lump to clear liquid
    Molecular weight:321.82

    Ref: 3B-C3946

    1g
    247.00€
    200mg
    99.00€
  • Clopidogrel

    Controlled Product
    CAS:
    <p>Methyl (2S)-2-(2-chlorophenyl)-2-(9-thia-4-azabicyclo[4.3.0]nona-7,10-dien-4-yl)acetate, also know as Clopidogrel, is a potent inhibitor of the platelet aggregation. It reduces blood clotting by inhibiting the ADP receptor on the surface of platelets, thereby inhibiting the aggregation and adhesion of platelets. Clopidogrel has been shown to be effective in preventing thrombosis, myocardial infarction (heart attack), and stroke. Clopidogrel inhibits the activity of cytochrome P450 3A4 (CYP3A4) and p2Y 12 receptors. Clopidogrel has been shown to have synergic effects with nonsteroidal anti-inflammatory drugs (NSAIDs). The polymorphic nature of Clopidogrel can be monitored using a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for quantification in biological samples such as human serum and plasma.</p>
    Formula:C16H16ClNO2S
    Purity:Min. 95%
    Color and Shape:Powder
    Molecular weight:321.82 g/mol

    Ref: 3D-FM61519

    50mg
    227.00€
    100mg
    361.00€
    250mg
    642.00€